HistoIndex Is Now MedTech Imaging Partner of Strategic Collaboration by A*STAR's GIS, NUS Medicine and Novo Nordisk

HistoIndex is very happy to be on board this strategic research collaboration by A*STAR's GIS, NUS Medicine and Novo Nordisk as one of the MedTech imaging partners.

Our AI-based stain-free digital pathology platform will contribute towards identifying patients with nonalcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), by providing a precise quantification of NAFLD/NASH characteristics.

Click to read more on how this study can further support the development of effective diagnostics and therapies.

GIS, NUS, AND NOVO NORDISK TEAM UP TO STUDY NON-ALCOHOLIC FATTY LIVER DISEASE IN ASIAN POPULATIONS